Novo Nordisk’s drug Wegovy has been approved for use in the UK

Novo Nordisk weight-loss drug Wegovy has received approval from the UK regulator for use to reduce the risk of serious heart problems or strokes in overweight and obese adults, the agency said Tuesday.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO